Effect of Moringa leaves in Cervical cancer patients.
Phase 3
- Conditions
- Health Condition 1: C539- Malignant neoplasm of cervix uteri, unspecified
- Registration Number
- CTRI/2024/02/062653
- Lead Sponsor
- Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Non metastatic cervical cancer patients
Hemoglobin level between 7-10.9 gm/dl
Serum ferritin level less than 30mcg/
Exclusion Criteria
Any other form of anemia
Patient with known chronic ailments like cardiac disorders, chronic infections
Known allergy to Iron and related products
Known liver and kidney disorders
Those who have not completed all the investigations as proposed
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean hemoglobin at the end of interventionTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method Proportion of participants with Hb more than or equal to 11gm/dl <br/ ><br>Mean change in RBC indices and Iron indices <br/ ><br>proportion of participants achieving normal RBC indices and iron indices <br/ ><br>Incidence of any adverse events <br/ ><br>Compliance to treatment <br/ ><br>Change in quality of lifeTimepoint: 30 days